Venture capitalist and businessman Stephen Jurvetson is joining an expanding group of prominent investors who are backing research into psychedelic ventures.
Today, 2:07 PM
The FDA has approved Daré Bioscience Inc (NASDAQ:DARE) Xaciato (DARE-BV1) to treat bacterial vaginosis. Xaciato is a thermosetting bioadhesive hydrogel containing…
Today, 2:03 PM
A British study evaluating mixing COVID-19 vaccines showed a better immune response in people after the first dose of AstraZeneca
Today, 1:33 PM
Legend Biotech Corporation’s (NASDAQ:LEGN) collaborating partner Janssen Pharmaceutical has submitted a marketing application to the Japanese Ministry of Health, Labour and Welfare (MHLW)…